The third COVID-19 Conversations webinar will discuss: emerging evidence on SARS-CoV-2 surface and aerosol transmission and stability; emerging and promising treatment modalities for COVID-19, including convalescent plasma and hydroxychloroquine and chloroquine; and the ethical implications and considerations for treating those who are ill with therapeutics approved via an emergency use authorization.
The webinar’s panel of expert speakers:
- Margaret “Peggy” Hamburg, MD (Moderator) – Foreign Secretary, National Academy of Medicine, and former FDA Commissioner
- John-Martin Lowe, PhD – Assistant Vice Chancellor for Interprofessional Health Security Training and Education and Associate Professor of Environmental, Agricultural, and Occupational Health, University of Nebraska Medical Center
- Arturo Casadevall, MD, PhD – Chair, Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health
- R. Alta Charo, JD – Warren P. Knowles Professor of Law and Bioethics, University of Wisconsin-Madison
Speaker presentations will be followed by a Q&A session with the webinar audience.
Register here.
Related